PillRx only · Injection, Powder, Lyophilized, For Solution · Intracavernous
Alprostadil
Brands: Caverject · Caverject Impulse · Edex · Alprostadil
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$151.555
Latest avg · Jul 22, 2026
-32%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
50
Rx · 2026 Q1
14
Units dispensed
-75%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Endo USA, Inc. | unknown | 6 | SUPPLYING |
| Pharmacia & Upjohn Company LLC | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 22, 2017RECALLRecall (Class II): Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in Germany for: Actient Phar…
Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks — Recalling firm: Endo Pharmaceuticals, Inc. — Nationwide within the United States